Clinical Trials for Bliss Biopharmaceutical

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Bliss Biopharmaceutical

Clinical Trials (3)

NCT06188559
A Study of BB-1701 in Previously Treated Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive or HER2-low Unresectable or Metastatic Breast Cancer
PHASE2Active, not recruiting
135 participants
Started: Apr 10, 2024 · Completed: Mar 31, 2026
1 condition2 sponsors49 locations
NCT06241898
A First-in-human of Multiplle Doses of BB-1709 in Subjects With Locally Advanced/Metastatic Solid Tumors
PHASE1Recruiting
300 participants
Started: Oct 1, 2023 · Completed: Dec 30, 2026
1 condition1 sponsor1 location
NCT05217693
A First-in-human of Multiplle Doses of BB-1705 in Subjects With Locally Advanced/Metastatic Solid Tumors
PHASE1Recruiting
288 participants
Started: Jun 1, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor7 locations